25th Jan 2016 10:18
LONDON (Alliance News) - Quantum Pharma PLC said Monday that it has launched Mucodis mouthwash via Colonis, part of its Niche Pharmaceuticals division.
The mouthwash has been developed to prevent oral mucositis, a common and debilitating complication of chemotherapy and radiation for patients being treated for cancer.
The launch of the mouthwash follows on from the launch of the Mucodis Oromucosal Spray last November, used for the treatment of the same condition after it has developed. However, the mouthwash has an indication for the prevention of oral mucositis in patients as they begin treatment.
Quantum Pharma expects to launch further Mucodis products in its financial year to end-January 2017.
Shares in Quantum Pharma were up 4.9% at 75.00 pence Monday morning.
By Hana Stewart-Smith; [email protected]; @HanaSSAllNews
Copyright 2016 Alliance News Limited. All Rights Reserved.
Related Shares:
Quantum Pharma